Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis

CCL17 drives the expression of MMP9 and MMP13 expression via ERK1/2 and NF-κB signaling pathways in rheumatoid arthritis.

Cellular signalling·2026

Hydrogen sulfide generated by cystathionine gamma lyase inhibits lysyl oxidase and protects against calcific tendinopathy.

Journal of orthopaedic translation·2026

Protocol to study the contribution of biomechanics in osteoarthritis development using a cartilage-on-chip model.

STAR protocols·2026

Allosteric activators of cystathionine γ lyase to augment endogenous hydrogen sulfide and inhibit pathologic calcification.

Pharmacological research·2025

Screening of the FDA-approved drug library identifies CCL17 inhibitors that block arthritic pain.

Scientific reports·2025

Therapeutic blockade of CCL17 in obesity-exacerbated osteoarthritic pain and disease.

PloS one·2025

Regional distribution of adult rheumatologists.

Arthritis and rheumatism·2013

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Arthritis and rheumatism·2013

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Arthritis and rheumatism·2013

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

Arthritis and rheumatism·2013

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Arthritis and rheumatism·2013

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Arthritis and rheumatism·2013

Long-term outcome of pediatric anti-complement factor H antibody-associated atypical hemolytic uremic syndrome receiving abbreviated plasma exchange: a retrospective study from a single center.

Journal of nephrology·2026

[Therapeutic apheresis in first-line treatment of hematological disorders - an evidence-based review].

Therapeutische Umschau. Revue therapeutique·2026

Same-day rescue plerixafor during leukapheresis is safe and effective in allogeneic donors suboptimally responding to granulocyte colony-stimulating factor mobilization.

Transfusion·2026

Platelet-erythrocyte complex production is exacerbated by histones and protected by small polyanion histone neutralizing compounds.

Platelets·2026

Changing the treatment paradigm in beta thalassemia.

Folia medica·2026

Noninvasive Thrombus Imaging in Patients With Ischemic Stroke.

Circulation·2026

Related Experiment Videos

Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis

Related Concept Videos

CCL17 drives the expression of MMP9 and MMP13 expression via ERK1/2 and NF-κB signaling pathways in rheumatoid arthritis.

Hydrogen sulfide generated by cystathionine gamma lyase inhibits lysyl oxidase and protects against calcific tendinopathy.

Protocol to study the contribution of biomechanics in osteoarthritis development using a cartilage-on-chip model.

Allosteric activators of cystathionine γ lyase to augment endogenous hydrogen sulfide and inhibit pathologic calcification.

Screening of the FDA-approved drug library identifies CCL17 inhibitors that block arthritic pain.

Therapeutic blockade of CCL17 in obesity-exacerbated osteoarthritic pain and disease.

Regional distribution of adult rheumatologists.

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Long-term outcome of pediatric anti-complement factor H antibody-associated atypical hemolytic uremic syndrome receiving abbreviated plasma exchange: a retrospective study from a single center.

[Therapeutic apheresis in first-line treatment of hematological disorders - an evidence-based review].

Same-day rescue plerixafor during leukapheresis is safe and effective in allogeneic donors suboptimally responding to granulocyte colony-stimulating factor mobilization.

Platelet-erythrocyte complex production is exacerbated by histones and protected by small polyanion histone neutralizing compounds.

Changing the treatment paradigm in beta thalassemia.

Noninvasive Thrombus Imaging in Patients With Ischemic Stroke.

Related Experiment Videos

Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis

Related Concept Videos

Related Articles